Tag: FluoSphera

  • FluoSphera secures €1.23M to expand human-based preclinical platform

    FluoSphera, a Swiss biotech startup focused on drug safety and efficacy testing, has raised €1.23 million (CHF1.15 million) in funding. The round was led by Soulmates Ventures and a Swiss business angel, with participation from IndieBio New York. Developing a new drug is a lengthy and costly process, and a large proportion of drug candidates read more

    Written by

    dweetleapp
    FluoSphera secures €1.23M to expand human-based preclinical platform